2016
DOI: 10.1074/jbc.m116.715219
|View full text |Cite
|
Sign up to set email alerts
|

Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
117
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 65 publications
(125 citation statements)
references
References 49 publications
7
117
1
Order By: Relevance
“…We have drawn attention to studies indicating that the mechanism of therapeutic action of garlic-derived compounds is connected with their influence on ALDH activity. Kim et al indicated that the inhibition of ALDH activity was one of the mechanisms by which DATS suppressed the growth of breast cancer cells in vitro and in vivo [44]. It was observed that ALDH activity in the liver cells was reduced in mice intragastrically administered fresh garlic juice for eight days [45].…”
Section: Discussionmentioning
confidence: 99%
“…We have drawn attention to studies indicating that the mechanism of therapeutic action of garlic-derived compounds is connected with their influence on ALDH activity. Kim et al indicated that the inhibition of ALDH activity was one of the mechanisms by which DATS suppressed the growth of breast cancer cells in vitro and in vivo [44]. It was observed that ALDH activity in the liver cells was reduced in mice intragastrically administered fresh garlic juice for eight days [45].…”
Section: Discussionmentioning
confidence: 99%
“…Inhibition of the H3 K27me3 demethylases KDM6 A/B by GSKÀJ4 was shown to promote EMT in MCF-7 and HMLER cells, [74] suggesting that targeting epigenetic modifiers could provide the means to alter EMT for therapeutic purposes. Diallyl trisulfide (DAST) targets FOXQ1, [75] a protein implicated in embryonic development, cell cycle regulation, tissue-specific gene expression, cell signaling, and tumorigenesis in MCF-7 and SUM159 cells. It was shown that FOXQ1 is over-expressed in the CSCs, implying that this transcription factor may represent a suitable therapeutic target.…”
Section: Miscellaneousmentioning
confidence: 99%
“…DACH1 expression is lost in invasive BC . FoxQ1 is highly expressed in triple‐negative BC, displays an inverse correlation with the levels of DACH1 and localizes to DACH1 promoter in BC cells . The DATS treatment led to decrease of FoxQ1 protein levels along with inhibiting BC progression and causing a decline in BC stem cell population .…”
Section: Determinants Of Bc Risk: Considerations For Bc Prevention Anmentioning
confidence: 99%